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Itercellular communication between
epithelial cells and fibroblasts is important
"Nl for cellular regulation in a variety of organ
systems, particularly during development
~(1,2). It has been shown that fibroblasts in
~the lung or their secreted collagen fibers
can influence epithelial cell growth and
pU~ differentiation, whereas the epithelium
may control fibroblast growth (3-5). In
~~some cases, cell-cell interaction occurs
through secreted molecules (6,7), but there
X. Icoatan saso evidence that direct intercellular
-contact between these different cell types
may alter growth characteristics or epithe-
h~lal cell function (4,8).
~ These results have largely been
.~obtained from studies of cells isolated from
normal, adult lungs or from developing
lungs. Changes in this reciprocal epithelial
0*I~i~~ cell-fibroblast interaction may occur in
..~~~,, ~~~ injured lungs and so may alter the repara-
tive processes. The pulmonary epithelium
is a common target for a variety of envi-
ronmental toxins as well as circulating
drugs, and severe injury to this cell is fre-
quently associated with subsequent fibro-
blast proliferation (9). In considering the
mechanisms underlying pulmonary fibrosis
after epithelial injury, most studies have
focused on cytokine production and
9*W.t~dh~ fibroblast stimulation by macrophages in
articular (10). In the pulmonary re-
sponse to bleomycin, for example, recov-
ered alveolar macrophages have been
shown to secrete a fibroblast growth factor
and are also positive for transforming
growth factor f9 (TGF-fl), which is associ-
ated with increased collagen production
(11,12). However, bleomycin induces
epithelial injury (13,14), which may dis-
rupt the normal epithelial-fibroblast con-
trol system. It is not known whether this
change in the local microenvironment
alters proliferation of either cell type and
induces abnormal repair, which is charac-
..0 ~~terzed by epithelial proliferation, abnor-
mal differentiation, and extensive underly-
ing fibrosis.
In the present study, type 2 epithelial
cells and fibroblasts were isolated from rat
lungs 10 days after administration of
bleomycin, when epithelial injury is maxi-
Mal, and after 6 weeks when abnormal
repair with fibrosis occurs. This allowed us
..........I ~~to determine if there are changes in either
cell type at these two stages of injury and
repair, which could alter the proliferation
of the other cell ty-pe, either through a secreted
MOlecule or by a cell-contact-related process.
Materials and Methods
Male Sprague-Dawley rats (about 150 g)
were used. In a trial series, we injected ani-
mals intratracheally while they were under
mild barbiturate anesthesia with various
doses from 1 to 15 U ofbleomycin (kindly
provided by Bristol-Myers Squibb Co.,
Evansville, IN). Rats were killed by an
intraperitoneal barbiturate overdose at
intervals to 12 weeks, and the lungs were
processed for histologic examination.
Based on this trial, we chose a dose of 8
U/kg body weight in 0.3 ml sterile water
for further experiments. Two groups of 12
rats were injected, then 1 set was killed at
10 days, the other at 6 weeks. We lavaged
the lungs four times with 5 ml saline and
counted inflammatory cells by using a
hemocytometer. After centrifugation to
remove cells, we assayed the lavage fluid
for protein content. A sample oflung tis-
sue was taken to measure hydroxyproline
(HYP), and the remainder was processed
for microscopy (15). Control groups
received the same volume of water and
were killed at the same times. This experi-
ment established that the 8 U/kg
bleomycin induced acute lung injury at 10
days, followed by pulmonary fibrosis at 6
weeks.
Celi Isolation
We isolated type 2 epithelial cells and
fibroblasts from normal rats and killed rats
at 10 days and 6 weeks after intratracheal
administration ofbleomycin or water. We
isolated type 2 cells using the method of
Dobbs et al. (16). Briefly, the lungs were
excised, and after perfusion, 4.3 U/ml elas-
tase was instilled into the trachea.
Subsequently, the lungs were minced and
filtered through successive nylon meshes
down to 7 gim to obtain a cell suspension
that was incubated in serum-free media in
petri dishes coated with IgG. We collected
nonadherent cells and spun them down;
viability by trypan blue was >90%. We
resuspended the cells in Dulbecco's modi-
fied Eagle's medium with 10% fetal bovine
serum for counting by hemocytometer and
seeding into culture dishes. Cells were iso-
lated from two rats, then pooled for each
experimental run. Previous experiments
using special stains and electron mi-
croscopy on cell pellets showed that cells
prepared in this way were >94% type 2
cells. We made a cytospin preparation of
each starting preparation to ensure purity;
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cells were only used when purity was
>90% with <2% macrophages present.
There was no morphologic difference be-
tween isolated cells from control or bleo-
mycin-treated lungs.
We prepared fibroblasts from rats in
the same group using a trypsin digestion
method as previously described and cul-
tured the fibroblasts to confluence (17).
Cells were passaged once before using
them in the experiments described below.
They stained >98% positive for vimentin
and negatively for factor VIII.
Culture System
Fibroblasts were seeded at a density of2 x
105 per well on a 24-well plastic culture
dish and allowed to adhere for 1 hr. We
seeded epithelial cells at 4 x 105 per well
into a well insert, which had a filter as a
base (Millicell-CM, Millipore Corp.,
Bedford, MA). These filters were coated
with 50 ,ug rat-tail collagen just before
using them to improve cell attachment.
Other epithelial cells were seeded directly
onto a fibroblast layer and co-cultured.
Using various combinations, we studied 1)
epithelial cells alone; 2) fibroblasts alone;
3) epithelial cells exposed to secretions of
underlying fibroblasts; 4) fibroblasts
exposed to secretions ofoverlying epithelial
cells; and 5) co-cultures with epithelial cells
and fibroblasts in direct contact.
For both bleomycin groups, we cul-
tured isolated epithelial cells and fibroblasts
under the five conditions outlined above.
We carried out additional experiments in
which cells isolated from normal rats were
cultured with cells from bleomycin-
exposed lungs; for example, normal type 2
cells were cultured over fibroblasts from
bleomycin-exposed lungs and vice versa.
Celi Growth
Cells were cultured as described for 1 day
then changed to serum-free conditions for
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Figure 1. Number of cells (mean ± SE) lavaged
from noninjected control and bleomycin (BLM)-
treated rats after 10 days and 6 weeks. (Open
bars) Alveolar macrophages; (shaded bars) poly-
morphonuclear leukocytes. *p< 0.01 compared to
water-injected control atthe corresponding time.
a further day. In some experiments, we
quantitated the growth of each cell type
by counting cell numbers after trypsiniza-
tion of the wells and filters separately,
then by using a hemocytometer. In most
experiments, we measured DNA synthesis
by adding tritiated thymidine (3HT) at
0.1IgCi/ml for the final 4 hr of culture,
when the cells were rinsed well and
scraped off for scintillation counting.
The thymidine uptake (dpm) was taken as
the mean of four wells for each culture
series. In addition, from one additional
well, we removed cells and made dupli-
cate cytospin preparations from each sus-
pension. Slides were subsequently dipped
in Kodak NTB2 emulsion in the dark
room under a red filter. After 2 weeks in
total darkness, we developed the slides
and stained them with toluidine blue.
For each time period, we calculated the
percentage of cells labeled after counting
500 cells per slide.
To quantitate DNA synthesis by the
individual cell types in the co-cultures, we
stained cytospin preparations for cytoker-
atin and vimentin using standard
immuno-pe]
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Growth Factor Studies
A few additional experiments using cells
from different rats were set up to test the
effects of selected, known growth factors
and their antibodies on epithelial cell pro-
liferation. Agents used at various dose lev-
els were tumor necrosis factor (TNF-0c),
platelet-derived growth factor (PDGF),
TGF-a, TGF-fl, epidermal growth factor
(EGF), and their respective antibodies (R
and D Systems, Minneapolis, MN).
Effects were quantitated by counting
thymidine-labeled cells in autoradiographs
using the same experimental outline
described earlier.
Statistics
We used isolated cells from at least four
different preparations for each ofthe con-
ditions studied. Means ± SEs were calcu-
lated for each experimental group and
compared to the corresponding control for
significance using the Student's ttest.
Results
In vivoStudies
roxidase methods (18), then The intratracheal injection ofwater causes
I slides for autoradiography. a mild inflammation response, which in
d us to count separately the our experience ceases by 3-5 days. In this
ibeled nuclei ofepithelial cells experiment, no change in lung cells, lavage
asts from the same culture protein, or lung HYP over noninjected
Lrly, slides of "pure" epithelial controls was found at the times studied.
lined for vimentin so that any The number of alveolar macrophages
taminating fibroblasts could (AM) recovered by bronchoalveolar lavage
d from the cell counts. (BAL) from bleomycin-injected lungs was
more than double control values at 10 days
and remained above normal at 6 weeks
(Fig. 1). Few polymorphonuclear leuko-
cytes (PMN) were recovered from normal
* lungs, but signficantly higher numbers
were present in BAL from bleomycin-
injected lungs. This inflammatory
response was confirmed by measuring the
protein content ofBAL fluid (Fig. 2). The
g* protein level was greatly increased 10 days
after bleomycin, and, although it fell sub-
sequently, it was still above control levels
after 6 weeks. We indexed changes in lung
collagen by the HYP level, which was
unchanged at 10 days after treatment but
was significantly increased after 6 weeks
(Fig. 2).
Lung morphology confirmed the gen-
eral biochemical findings. At 10 days, dif-
fuse injury to the alveolar walls was seen,
the tissue was edematous, and the alveoli
______________________Ccontained AM and PMN (Fig. 3A). By 6
CONTROL 10d BLM 6w BLM weeks, fewer cells were seen in alveolar
spaces; the main change was in the pul-
monary interstitium, which was thicker
tein content of bronchoalveolar than normal due to excess fibroblasts and
nd lung content of hydroxyproline
ijected controls and in lungs at 10 collagen (Fig. 3B). Evidence ofepwthelal 'eeks after bleomycin treatment repair was seen, as some alveoli were lined
I1 compared to water-injected con- by cuboidal cells rather than the usual mix-
espondingtime. ture oftype 1 and 2 cells.
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In vitro Studies: 10-Day Bleomycin
;........ q.... Group
We studied growth characteristics of
epithelial cells and fibroblasts using 3HT
uptake. Type 2 cells isolated from normal
lung (N-EP) or from lungs 10 days after
bleomycin injection (B-EP) incorporated
low levels of 3HT (Fig. 4). When either
set ofEP cells was cultured over fibroblasts
from normal (N-FB) orbleomycin (B-FB)-
treated rats in the lower culture chamber,
thymidine incorporation ofEP cells signifi-
cantly increased (Fig. 4). Proliferation was
confirmed by counting the number of EP
cells, which increased about 70% when EP
were cultured over FB.
When fibroblasts were grown alone, N-
FB and B-FB incorporated 3HT equally
(Fig. 5). However, when fibroblasts were
cultured in wells beneath EP cells, DNA
synthesis was significantly lower than in
fibroblasts grown alone. In particular, a
secretion ofB-EP depressed 3HT uptake in
B-FB to a greater extent (Fig. 5).
In vitro Studies: 6-Week Bleomycin ~j. #||j < p -ts Group
Epithelial cells isolated from this older
group ofrats, normal or treated, showed a
slightly lower level of 3HT uptake.
However, in each experimental group, N-
EP and B-EP cells showed increased DNA
synthesis when cultured on inserts over N-
MM_ __ FB or B-FB (Fig. 6). However, when
using cells derived from bleomycin-treated
rats, a lower increase in 3HT uptake by EP
cells was observed compared to that seen
when only normal cells were used (N-EP,
N-FB).
The 3HT uptake of normal fibroblasts
was significantly reduced when they were
exposed to factors secreted-by N-EP or B-
EP (Fig. 7). GrowthofB-FB wassuppressed
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Figure 4. Incorporation of tritiated thymidine (3HT)
by epithelial cells (EP) from normal (N) lungs or 10
days after bleomycin (B) treatment. The EP cells
Figure 3. Lung sections after bleomycin (X 550). (A) At 10 days, diffuse alveolar injury is seen with intersti- were cultured alone or on a filter above fibrob-
tial edema. Many inflammatory cells are present in the air spaces. (B) At 6 weeks, the interstitium is lasts (FB). *p < 0.05 compared to corresponding
greatlythickened byfibroblasts and collagen. EP cells alone.
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Figure 5. Incorporation of 3HT by fibro-blasts
(FB) from normal (N) lung or 10 days after
bleomycin (B) treatment. The FB were cultured
alone or beneath epithelial (EP) cells.*p < 0.05
compared to corresponding Fb cells alone; ap <
0.05 compared to all other groups.
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Figure 6. Epithelial cells (EP) isolated from control
lungs (N) and from lungs 6 weeks after bleomycin
(B) treatment. The EP were cultured alone or over
fibroblasts (FB). ap < 0.05 compared to all other
groups.
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Figure 7. Fibroblasts (FB) isolated from control
lungs (N) and from lungs 6 weeks after bleomycin
(B) treatment. The FB were cultured alone or
below epithelial cells (EP). *p < 005 compared to
corresponding FB cells alone.
by N-EP cells, but no effect was seen when
B-FB were cultured beneath B-EP (Fig. 7).
Most of the experiments were carried
out using 3HT uptake (dpm) as the end
point. Other experiments were also carried
out using this group of rats to determine
cell counts to confirm cell division as
opposed to DNA synthesis only. We also
used autoradiography to establish the iden-
tity ofcells in DNA synthesis. The results
confirm that epithelial cells cultured over,
but separated from, fibroblasts show signif-
icantly increased labeling and cell numbers
compared to cells cultured alone (Table 1).
This occurred using normal cells, and to a
lesser extent with cells from bleomycin-
treated lungs. The autoradiographic study
also allowed quantitation oflabeled cells in
co-cultures. When EP and FB were co-
cultured, the stimulatory effect on the EP
population was lost. Total cell numbers in
the co-cultures were high due to fibroblast
growth (data not shown), but only about
2.5-3% ofEP cells were labeled in autora-
diographs, a value equal to that found
when EP cells were cultured alone (Table
1). This contrasts to an EP labeling value
of7-12% when these cells were exposed to
a fibroblast secretory product.
In vitro Growth Factor Studies
In a preliminary set of studies to identify
the fibroblast secretory product responsible
for epithelial growth stimulation, antibod-
ies to the well-known growth factors
PDGF, EGF, TNF-a, TGF-a and TGF-f3
were added at various concentrations to the
culture system. The increase in 3HT
incorporation by EP cells grown over fibro-
blasts was not blocked by antibodies to any
of these growth factors (data not shown).
The antibodies were biologically active
because lower growth was seen in the
underlying fibroblasts. One surprising re-
sult occurred using anti-TGF-f9: it seemed
to stimulate EP growth. This result was
investigated more closely, and results are
shown in Table 2.
Addition ofpure TGF-f to the epithe-
lial cells cultured over fibroblasts lowered
the percentage of labeled EP cells. When
the anti-TGF-g was used, 3HT incorpora-
tion by EP cells alone, and in particular
those maintained over fibroblasts, was sig-
nificantly increased (Table 2).
Discussion
Pulmonary fibrosis is a common sequel to
severe or chronic injury to the lung. Most
research into the underlying mechanisms
of fibroblast stimulation has concentrated
on cytokine release by macrophages
because these cells secrete a variety ofhor-
monelike molecules that enhance fibroblast
growth and collagen production (10).
This is also true of alveolar macrophages
recovered from fibrotic lungs injured by
the antineoplastic drug bleomycin (11).
However, it has been previously shown
that intravenously or intratracheally inject-
ed bleomycin initially damages endothelial
and epithelial cells of the lung, and repair
is abnormal leading to fibrosis (13). De-
spite severe epithelial damage, the effects of
bleomycin on the local epithelial-fibroblast
control system have not been investigated.
The model of intratracheal injection
permits a lower dose to be instilled directly
to the lung and is a useful model ofgener-
ating rapid fibrosis (14). We chose a dose
level of bleomycin to allow study of these
two cell types isolated from lungs at differ-
ent stages ofthe injury-repair cycle. At 10
days after injection, there is acute lung
injury indexed by the inflammatory
response, a high level of alveolar protein,
and morphologic changes, all of which
indicate diffuse alveolar injury, especially
to type 1 cells. From these lungs, isolated
type 2 cells, although probably injured to
some extent, were certainly viable and
could be maintained in culture. At 10-
days in vivo, there was no change in colla-
gen levels in the lung. In contrast, 6 weeks
after bleomycin treatment, fibrosis was evi-
dent biochemically and by lung morpholo-
gy. The acute inflammatory reaction had
subsided and the blood-air barrier was
much less permeable. Previous studies
have shown that the peak of epithelial
repair is over by this time (19), when epi-
thelial cells and fibroblasts were also isolat-
ed for in vitrostudy.
Fibroblasts from each group, cultured
alone, proliferated rapidly and approxi-
mately equally as measured by cell counts
and thymidine incorporation. When nor-
mal fibroblasts were cultured in a lower
chamber beneath epithelial cells, their
growth was slower and a significant
decrease in fibroblast DNA synthesis was
observed. This was also true using cells
from the 10-day bleomycin group; fibro-
blast growth was particularly suppressed
when fibroblasts were exposed to secreted
products of epithelial cells from the same
rats (Fig. 5). When cells were prepared
from the fibrotic lungs, epithelial cells were
still able to decrease HT uptake by normal
fibroblasts, but these cells had no effect on
fibroblasts from bleomycin-treated rats.
This indicates that a product secreted by
epithelial cells, which has some fibroblast
inhibitory effects on normal cells, is not
secreted in fibrotic lung in which excess
fibroblast growth occurs. This suggests that
in normal cells, localized fibroblast control
is mediated through the overlying epitheli-
um. However, the epithelial surface 6
weeks after bleomycin treatment is not nor-
mal in vivo, and various cuboidal epithelial
cell forms have been described (19). These
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Table 1. Growth of epithelial cells (EP) from normal (N) lungs or from lungs 6 weeks after bleomycin treatment (B), cultured alone, or exposed to fibroblast (FB)-
derived factors
N-EP N-EP N-EP N-EP B-EP B-EP B-EP B-EP
N-EP over with over with B-EP over with over with
alone N-FB N-FB B-FB B-FB alone N-FB N-FB B-FB B-FB
% EP cell 2.6±0.2 11.5 ± 1.1* 2.8±0.3 8.8±0.8* 2.3±0.2 2.9±0.3 10.0± 1.0* 2.9±0.4 7.4± 0.7* 2.5±0.5
label
EP cell 2.0 ±0.3 3.2 +0.3* - 2.6±0.4 1.8±0.2 2.9± 0.3* 2.5±0.3
numberx 105
* p< 0.05 compared to corresponding EP alone.
may be functionally deficient in producing
the fibroblast inhibitor as shown here and
so may contribute to the development of
fibrosis.
The identity of the inhibitory mole-
cule is not known. Although macro-
phages are a well-recognized source of
cytokines, the low number present in our
epithelial cell preparation makes it more
likely that the fibroblast inhibitory mole-
cule is produced by type 2 cells. One
candidate is TGF-f, which has been
shown in lung epithelial cells in
bleomycin-treated lungs, though it was
associated more with areas of increased
collagen deposition (12). Another possi-
ble inhibitor is prostaglandin E2 (PGE2),
which is secreted by type 2 cells in culture
(19) and is secreted in larger amounts by
these cells during injury such as exposure
to silica (21). Because PGE2 is associated
with reduced fibroblast growth in the
lung, it may function at a local level in
epithelial-fibroblast growth control. It
has been shown previously that alveolar
epithelial cells secrete a low-molecular-
weight factor that inhibits proliferation of
interstitial cells (22). Evidence ofepithe-
lial control of fibroblast growth has also
been found in organ culture studies in
which fibroblast growth is promoted in
the absence of epithelium and is con-
trolled as the epithelial surface is restored
(23,24). The present results suggest that
epithelial cells are capable of fibroblast-
growth control through diffusion of a
secreted factor, but in a fibrotic lung, this
inhibitory effect is lost.
In a reciprocal interaction, epithelial
cell proliferation appears to be promoted
by exposure to a diffusible product oflung
fibroblasts. Type 2 cells isolated from con-
trol or treated rats incorporated a low level
of3HT and showed little division; as deter-
mined by autoradiography, only about
2-3% of cells were labeled. However,
when these cells were cultured on a filter
insert with fibroblasts in the lower cham-
ber, all parameters ofcell growth were sig-
nificantly increased, whether using cells
from normal or bleomycin-injected rats.
This indicates that a fibroblast-derived fac-
tor is capable of stimulating epithelial
growth and so may accelerate repair. It is
interesting to note that this stimulation
occurred through a secreted, diffusing fac-
tor. When co-cultures were studied,
fibroblast growth predominated, but when
autoradiographs were examined, epithelial
cell labeling was low and identical to levels
seen in pure epithelial cultures. This sug-
gests that direct epithelial cell-fibroblast
contact induces an inhibitor to epithelial
growth. Similar results were obtained ear-
lier using fetal cells, whereby direct
cell-cell contact between these two cell
types was associated with reduced epithe-
lial cell growth but enhanced type 2 cell
differentiation (4).
Pure type 2 cells proliferate poorly
under normal culture conditions and re-
quire addition ofspecific growth factors to
stimulate cell division (7,25). The identity
of the fibroblast-derived factor that pro-
motes epithelial growth in the present
study is not known; it could be one or a
Table 2. Percentage (mean + SE) of 3H-thymidine- labeled epithelial cells (EP) from normal (N) and
bleomycin (B)-injected rats after culture alone or overfibroblasts (FB)
N-EP B-EP B-EP
over over over
N-EP N-FB B-EP B-FB N-FB
Cells alone 2.5 ±0.2 4.5 ±0.5 3.2 ±0.7 4.4 ±0.7 7.2 ± 1.0
+1 ngTGF-B 2.7 ±0.2 4.0±0.4 2.8±0.2 3.6±0.4 5.4±0.6
+5 ng TGF-B 2.0 ±0.1 3.8 ±0.4 1.6 ±0.2** 2.9 ±0.4** 3.7 ±0.5**
+5gg anti-TGF-1 4.8±0.8* 6.5±0.8 3.2±0.6 6.7±0.8 10.6±1.3
+20 pg anti-TGF-1 4.1 ±0.4* 7.8 ± 1.0* 4.2±0.7 8.8± 1.1* 13.6± 1.4*
In all cases, EP cells grown over FB show a greater labling percentage (p < 0.05) than EP grown alone.
TGF,transforming growth factor.
*p < 0.05,treated cells compared to corresponding untreated cells.
**p < 0.05, treated cells compared to corresponding untreated cells.
combination of several fibroblast-derived
growth factors that promote lung cell pro-
liferation (7). Fibroblast-conditioned
media has been shown to produce a com-
petence factor for fetal lung epithelial cells
(5), and it has also been shown that lung
fibroblasts produce a growth factor for
bronchial epithelial cells (26). In prelimi-
nary experiments to identify the factor, we
were unable to block the increase in epi-
thelial growth using antibodies to PDGF,
TNF-a, TGF-a or EGF. When TGF-f
was added to type 2 cells in culture over
fibroblasts, the usual growth increase was
not seen, suggesting thatTGF-g may act as
an antagonist to the epithelial growth fac-
tor. This was supported when the addition
ofanti-TGF-fl to the culture system result-
ed in a significant increase in type 2 cell
labeling. Lung fibroblasts are known to
secrete TGF-f (27) and its regulation may
play a key role in both epithelial and
fibroblast cell behavior during injury and
repair. This aspect ofthe epithelial-fibrob-
last interaction is now under more detailed
study.
The existence of a fibroblast-derived
growth factor for epithelial cells could be
important in providing a stimulus to lung
repair after type I cell necrosis, when rapid
regeneration of the epithelial surface by
type 2 cell proliferation is a key event in
the restoration of normal lung structure
(23,28). Because type 1 cell injury is a
common event when the lung is exposed
to various environmental toxins, the
changes in cellular control seen here after
bleomycin may represent a general
response to air- or bloodborne agents that
are capable of inducing fibrosis. Control
mechanisms involving epithelial
cell-fibroblast interactions may be impor-
tant in regulating normal repair in a highly
localized manner. This system may be
effective in repairing acute focal injury. It
may be speculated that, in cases of more
severe epithelial injury, this localized con-
trol process is supplemented by more gen-
eralized mechanisms of repair in which
chronic inflammation, macrophage activa-
tion, and general cytokine networks are
involved.
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